Computational Fluid Dynamics Predicting Intraprosthetic Thrombus Formation and Progression Following EVAR

November 20, 2024 updated by: Wei Wang, Xiangya Hospital of Central South University

Computational Fluid Dynamics Predicting Intraprosthetic Thrombus Formation and Progression Following Endovascular Aortic Repair: a Two-center Retrospective Study

Intraprosthetic thrombus (IPT) formation and its progression to limb graft occlusion (LGO) are significant complications following endovascular aneurysm repair (EVAR). Morphological metrics based on preoperative CTA have limited predictive value for these complications. This study aims to assess the potential of computational fluid dynamics (CFD) in predicting IPT formation and its progression to LGO after EVAR.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

72

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Patients undergone endovascular aneurysm repair.

Description

Inclusion Criteria:

  1. Aged 18 and above;
  2. Patients undergone endovascular aneurysm repair;
  3. Signed informed consent forms, willing to receive treatments.

Exclusion Criteria:

  1. inflammatory aortic aneurysm;
  2. patients diagnosed with connective tissue diseases;
  3. patients diagnosed with atrial fibrillation;
  4. patients lacking post-operative CTA;
  5. Patients who are participating in other clinical projects;
  6. Patients are not suitable to participate in this study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intraprosthetic thrombus Group
presence of intraprosthetic thrombus according to the postoperative CTA
Non-intraprosthetic thrombus Group
absence of intraprosthetic thrombus according to the postoperative CTA

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Degree of intraprosthetic thrombus in limb graft
Time Frame: From January 2014 to June 2024
Evaluate the area of thrombus occupying the lumen using postoperative CTA
From January 2014 to June 2024

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Disease-related complications
Time Frame: From January 2014 to June 2024
Disease-related complications associated with intraprosthetic thrombus or limb graft occlusion, such as thromboembolic events
From January 2014 to June 2024

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2014

Primary Completion (Actual)

June 30, 2024

Study Completion (Actual)

June 30, 2024

Study Registration Dates

First Submitted

November 17, 2024

First Submitted That Met QC Criteria

November 20, 2024

First Posted (Estimated)

November 22, 2024

Study Record Updates

Last Update Posted (Estimated)

November 22, 2024

Last Update Submitted That Met QC Criteria

November 20, 2024

Last Verified

November 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 2024030373

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Intraprosthetic Thrombus

Subscribe